MINOIA, FRANCESCA SERENA
 Distribuzione geografica
Continente #
EU - Europa 2.772
AS - Asia 182
SA - Sud America 18
NA - Nord America 10
AF - Africa 6
OC - Oceania 1
Totale 2.989
Nazione #
IT - Italia 2.763
SG - Singapore 71
VN - Vietnam 47
CN - Cina 44
BR - Brasile 12
US - Stati Uniti d'America 9
ID - Indonesia 8
HK - Hong Kong 4
AR - Argentina 3
IN - India 3
MA - Marocco 3
EC - Ecuador 2
IQ - Iraq 2
NL - Olanda 2
RS - Serbia 2
AZ - Azerbaigian 1
DZ - Algeria 1
FI - Finlandia 1
GB - Regno Unito 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.989
Città #
Genova 1.237
Genoa 961
Rapallo 323
Vado Ligure 232
Singapore 25
Ho Chi Minh City 21
Beijing 11
Hanoi 9
Bordighera 7
Hong Kong 4
Da Nang 3
Haiphong 3
Jakarta 3
Tianjin 3
Delhi 2
Marrakesh 2
Orem 2
Quảng Ngãi 2
Srbobran 2
Tezze sul Brenta 2
Amsterdam 1
Ashburn 1
Baghdad 1
Bandung 1
Bangkok 1
Biên Hòa 1
Can Tho 1
Caracas 1
Casablanca 1
Caxias do Sul 1
Chongqing 1
Curitiba 1
Córdoba 1
Denpasar 1
Erbil 1
Fairfield 1
Ganja 1
Guayaquil 1
Hải Dương 1
Jundiaí 1
Lauro de Freitas 1
London 1
Maringá 1
Mascara 1
Montanhas 1
Nairobi 1
Nam Định 1
New Plymouth 1
Odintsovo 1
Panama City 1
Porto Alegre 1
Posadas 1
Quito 1
Resistencia 1
Reşiţa 1
Ribeirão Preto 1
Salto 1
San Jose 1
Santa Clara 1
Seeb 1
São Paulo 1
Tailândia 1
Taió 1
The Dalles 1
Thái Bình 1
Thái Nguyên 1
Tirunelveli 1
Xianyang 1
Yên Bái 1
Totale 2.903
Nome #
CD70 deficiency due to a novel mutation in a patient with severe chronic EBV infection presenting as a periodic fever 210
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 174
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 174
ABCC6 mutations and early onset stroke: Two cases of a typical Pseudoxanthoma Elasticum 160
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 159
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 158
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 156
Biologics in juvenile idiopathic arthritis: a narrative review 150
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis 149
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 147
Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation 144
Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis 134
Predictors of effectiveness of anakinra in systemic juvenile idiopathic arthritis 131
Clinical features and correct diagnosis of macrophage activation syndrome 131
Macrophage Activation Syndrome 114
Critical role of STIR MRI in early detection of post-streptococcal periostitis with dysproteinaemia (Goldbloom's syndrome) 109
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis 109
When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease 95
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis 95
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: A report of two cases 88
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey 77
CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REAL-LIFE DATA FROM A RETROSPECTIVE ITALIAN COHORT 63
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients 61
Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score 41
Response to: ‘MS score in systemic juvenile idiopathic arthritis: Suitable for routine use? ’ by Chi et al 35
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited 27
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force 2
Totale 3.093
Categoria #
all - tutte 11.608
article - articoli 11.608
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 0 0 0 21 68 31 17 41 12 25
2021/2022278 14 7 15 22 6 32 6 66 23 29 8 50
2022/2023369 25 48 8 28 66 41 4 25 69 2 44 9
2023/2024225 8 23 1 29 20 39 15 13 19 11 24 23
2024/2025670 19 29 40 36 63 68 83 145 19 29 65 74
2025/2026494 145 17 61 56 201 14 0 0 0 0 0 0
Totale 3.093